Linkedin Twitter

The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease

  • 01/10/2023
  • Geertsema S, Bourgonje AR, Fagundes RR, Gacesa R, Weersma RK, van Goor H, Mann GE, Dijkstra G, Faber KN.
Go to publication